Company Profiles

driven by the PitchBook Platform

Accolade

Accolade
2007 FOUNDED
PRIVATE STATUS
501-1K EMPLOYEES
Series E LATEST DEAL TYPE
$71.1M LATEST DEAL AMOUNT
11 INVESTORS
Description

Provider of consumer healthcare information services designed to reinvent the healthcare experience through compassion, science and technology. The company's consumer healthcare information services operates a healthcare engagement and influence platform for large self-insured employers and payment organizations, enabling consumers in determining healthcare benefits and to find healthcare providers.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Records Systems
Other Industries
Media and Information Services (B2B)
Decision/Risk Analysis
Primary Office
660 West Germantown Pike
Suite 500
Plymouth Meeting, PA 19462
United States

+1 (610) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Accolade’s full profile, request a free trial.

Accolade Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series E) 11-Aug-2016 $71.1M 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series E) 16-Jul-2015 000.00 0000 00000 Completed Generating Revenue
5. Later Stage VC 05-May-2014 00.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 12-Dec-2013 0000 000.00 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 01-May-2012 000 000.00 00000 Completed Startup
2. Early Stage VC (Series B) 29-Jun-2010 $16.9M $36.9M 000.00 Completed Startup
1. Early Stage VC (Series A) 01-Feb-2007 $20M $20M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Accolade Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 00,000,000 00.000000 00.00 00.00 00 00.00 00.00
Series D 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series B 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A2 12,899,999 $0.000100 $0.78 $0.78 1x $0.78 10.78%
Series A1 17,800,001 $0.000100 $0.56 $0.56 1x $0.56 14.88%
To view this company’s complete Cap Table, request access »

Accolade Investments & Acquisitions (1)

Company Name Date Type Deal Size Industry Lead Partner
000000 28-Apr-2014 000000000000000000 Communication Software 000000 00000
To view this company’s complete investment and acquisition history, request access »

Accolade Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Andreessen Horowitz Venture Capital Minority 000 0000 000000 0
Madrona Venture Group Venture Capital Minority 000 0000 000000 0
Independence Blue Cross Corporation Minority 000 0000 000000 0
McKesson Ventures Corporate Venture Capital Minority 000 0000 000000 0
Oak Hill Capital Partners PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Accolade Executive Team (44)

Name Title Board
Seat
Contact
Info
Rajeev Singh Board Member & Chief Executive Officer
Stephen Barnes Chief Financial Officer
John Stoddard Chief Operating Officer
Harish Naidu Chief Technology Officer
John Rollins Co-Founder, Executive Vice President & General Manager

8 Former Executives

You’re viewing 5 of 44 executives. Get the full list »

Accolade Board Members (15)

Name Representing Role Since Contact
Info
Charles Patton Accolade Board Observer 000 0000
Edgar Bronfman Jr. Accretive Board Member 000 0000
James Madden Carrick Capital Partners Board Member 000 0000
Jeffrey Jordan Andreessen Horowitz Board Member 000 0000
J. Michael Cline Self Co-Founder & Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 15 board members. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com